Last reviewed · How we verify

NCT04389996: COPICADS

COVID-19 Pandemic Impact on Patients With Cancer - a Danish Survey

Completed Last updated 28 July 2021
What this trial tests

trial testing No intervention in Cancer in 6,810 participants. Completed in 21 July 2021.

Timeline
14 May 2020
Primary endpoint
21 July 2020
21 July 2021

Quick facts

Lead sponsorOdense University Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment6,810
Start date14 May 2020
Primary completion21 July 2020
Estimated completion21 July 2021
Sites2 locations across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Odense University Hospital

Who can join

Adults 18 to 125, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The outbreak of coronavirus was categorized as a global pandemic in March 2020. The Danish government recommends social distancing during the COVID-19 pandemic. Long-term social distancing and fear of disease can lead to anxiety, depression and the feeling of loneliness. All these factors might affect the quality of life (QoL). The aim of this study is to investigate the overall QoL for patients with cancer during the COVID-19 pandemic with special focus on emotional functioning.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Cancer Management during COVID-19 Pandemic: Is Immune Checkpoint Inhibitors-Based Immunotherapy Harmful or Beneficial?
    Vivarelli S, Falzone L, Grillo CM, Scandurra G, et al · · 2020 · cited 63× · PMID 32785162 · DOI 10.3390/cancers12082237

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Cancer

Currently open trials in the same condition.

Other Odense University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04389996.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing